$PKE
PARK AEROSPACE CORP

2016 Q4 Form 10-Q Financial Statement

#000143774917000310 Filed on January 06, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4
Revenue $26.46M $34.32M
YoY Change -22.9% -1.03%
Cost Of Revenue $19.83M $24.03M
YoY Change -17.47% -7.88%
Gross Profit $6.634M $10.30M
YoY Change -35.57% 19.76%
Gross Profit Margin 25.07% 30.0%
Selling, General & Admin $4.604M $5.264M
YoY Change -12.54% -8.52%
% of Gross Profit 69.4% 51.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $720.0K $840.0K
YoY Change -14.29% -5.62%
% of Gross Profit 10.85% 8.16%
Operating Expenses $4.604M $5.264M
YoY Change -12.54% -8.52%
Operating Profit $1.917M $4.875M
YoY Change -60.68% 120.79%
Interest Expense $343.0K $355.0K
YoY Change -3.38% -1.66%
% of Operating Profit 17.89% 7.28%
Other Income/Expense, Net
YoY Change
Pretax Income $2.004M $4.747M
YoY Change -57.78% 129.43%
Income Tax $129.0K $638.0K
% Of Pretax Income 6.44% 13.44%
Net Earnings $1.875M $2.950M
YoY Change -36.44% 45.25%
Net Earnings / Revenue 7.09% 8.59%
Basic Earnings Per Share $0.09 $0.20
Diluted Earnings Per Share $0.09 $0.20
COMMON SHARES
Basic Shares Outstanding 20.24M 20.25M
Diluted Shares Outstanding 20.24M 20.25M

Balance Sheet

Concept 2016 Q4 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.8M $229.6M
YoY Change 4.01% -19.52%
Cash & Equivalents $106.5M $76.74M
Short-Term Investments $132.4M $152.9M
Other Short-Term Assets $2.300M $5.200M
YoY Change -55.77% 67.74%
Inventory $12.59M $12.64M
Prepaid Expenses
Receivables $16.01M $20.09M
Other Receivables $0.00 $0.00
Total Short-Term Assets $269.8M $267.6M
YoY Change 0.82% -17.32%
LONG-TERM ASSETS
Property, Plant & Equipment $19.33M $22.26M
YoY Change -13.14% -18.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.125M $1.273M
YoY Change -11.63% -57.83%
Total Long-Term Assets $40.29M $58.37M
YoY Change -30.97% -10.51%
TOTAL ASSETS
Total Short-Term Assets $269.8M $267.6M
Total Long-Term Assets $40.29M $58.37M
Total Assets $310.0M $325.9M
YoY Change -4.87% -16.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.692M $5.598M
YoY Change -16.18% 21.12%
Accrued Expenses $4.645M $4.884M
YoY Change -4.89% -14.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $13.75M
YoY Change -78.18% -21.43%
Total Short-Term Liabilities $13.61M $26.91M
YoY Change -49.41% -16.24%
LONG-TERM LIABILITIES
Long-Term Debt $69.75M $72.75M
YoY Change -4.12% -15.9%
Other Long-Term Liabilities $586.0K $1.095M
YoY Change -46.48% 319.54%
Total Long-Term Liabilities $70.34M $73.85M
YoY Change -4.75% -14.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.61M $26.91M
Total Long-Term Liabilities $70.34M $73.85M
Total Liabilities $127.9M $147.8M
YoY Change -13.48% -16.5%
SHAREHOLDERS EQUITY
Retained Earnings $26.66M $23.37M
YoY Change 14.05% -47.57%
Common Stock $2.096M $2.096M
YoY Change 0.0% 0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $15.02M $14.76M
YoY Change 1.78% 5447.74%
Treasury Stock Shares
Shareholders Equity $182.2M $178.1M
YoY Change
Total Liabilities & Shareholders Equity $310.0M $325.9M
YoY Change -4.87% -16.17%

Cashflow Statement

Concept 2016 Q4 2015 Q4
OPERATING ACTIVITIES
Net Income $1.875M $2.950M
YoY Change -36.44% 45.25%
Depreciation, Depletion And Amortization $720.0K $840.0K
YoY Change -14.29% -5.62%
Cash From Operating Activities $1.850M $4.810M
YoY Change -61.54% 71.17%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$90.00K
YoY Change 11.11% -40.0%
Acquisitions
YoY Change
Other Investing Activities $3.940M -$13.26M
YoY Change -129.71% -137.16%
Cash From Investing Activities $3.850M -$13.36M
YoY Change -128.82% -137.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.770M -4.520M
YoY Change -38.72% 105.45%
NET CHANGE
Cash From Operating Activities 1.850M 4.810M
Cash From Investing Activities 3.850M -13.36M
Cash From Financing Activities -2.770M -4.520M
Net Change In Cash 2.930M -13.07M
YoY Change -122.42% -136.16%
FREE CASH FLOW
Cash From Operating Activities $1.850M $4.810M
Capital Expenditures -$100.0K -$90.00K
Free Cash Flow $1.950M $4.900M
YoY Change -60.2% 65.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 pke Tax Expense Allocated To Undistributed Foreign Earnings
TaxExpenseAllocatedToUndistributedForeignEarnings
63958000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4692000
pke Number Of Insurance Carriers
NumberOfInsuranceCarriers
3
pke Number Of Sites Of Company Or Subsidiaries That Have Been Named For Potential Environmental Remediation Liability
NumberOfSitesOfCompanyOrSubsidiariesThatHaveBeenNamedForPotentialEnvironmentalRemediationLiability
4
pke Number Of Units Covered Under General Liability Insurance Coverage
NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage
3
pke Percentage Of Legal Defense And Remediation Costs Associated With Sites Reimbursed By Insurance Carriers
PercentageOfLegalDefenseAndRemediationCostsAssociatedWithSitesReimbursedByInsuranceCarriers
1
pke Percentage Of Stock Options Exercisable On Each Succeeding Year From Date Of Grant
PercentageOfStockOptionsExercisableOnEachSucceedingYearFromDateOfGrant
0.25
pke Percentage Of Stock Options Exercisable One Year From Date Of Grant
PercentageOfStockOptionsExercisableOneYearFromDateOfGrant
0.25
CY2015Q1 pke Stock Repurchase Program Percentage Of Outstanding Shares Authorized To Be Repurchased
StockRepurchaseProgramPercentageOfOutstandingSharesAuthorizedToBeRepurchased
0.06
CY2016Q2 pke Stock Repurchase Program Percentage Of Outstanding Shares Authorized To Be Repurchased
StockRepurchaseProgramPercentageOfOutstandingSharesAuthorizedToBeRepurchased
0.076
CY2016Q4 pke Stockolders Equity Including Treasury Stock
StockoldersEquityIncludingTreasuryStock
197177000
CY2016Q1 pke Stockolders Equity Including Treasury Stock
StockoldersEquityIncludingTreasuryStock
195887000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6155000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16013000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22583000
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1276000
CY2016Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2943000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4645000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4580000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1057000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1471000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167366000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
166398000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
361000
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
324000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
354000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
738000
CY2016Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
882000
CY2015Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1027000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
929000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
884000
CY2016Q4 us-gaap Assets
Assets
310044000
CY2016Q1 us-gaap Assets
Assets
314777000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
269753000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
272185000
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
139668000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
132821000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
108000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
132350000
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
139451000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
67935000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
64415000
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
139000
CY2016 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
372000
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
610000
CY2016 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
155000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106474000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97757000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141538000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76735000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8717000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-64803000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8475000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-65655000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2015Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20945634
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20234671
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2096000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
2096000
CY2016Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1535000
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3965000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6392000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13329000
CY2016Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
19828000
CY2015Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
24026000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
64355000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78074000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10674000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
43938000
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
43937000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2372000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2524000
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
242000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
852000
CY2016Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.064
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1
CY2015Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.134
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.121
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4000
CY2016 us-gaap Foreign Earnings Repatriated
ForeignEarningsRepatriated
61000000
CY2016Q4 us-gaap Gross Profit
GrossProfit
6634000
CY2015Q4 us-gaap Gross Profit
GrossProfit
10297000
us-gaap Gross Profit
GrossProfit
22655000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7565000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15307000
CY2016Q4 us-gaap Inventory Net
InventoryNet
12587000
CY2016Q1 us-gaap Inventory Net
InventoryNet
10214000
us-gaap Gross Profit
GrossProfit
32025000
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2004000
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4747000
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
129000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
638000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
759000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1852000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3045000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14255000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-58000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
449000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
25000000
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
9833000
CY2016Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
9833000
CY2016Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
430000
CY2015Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
227000
us-gaap Interest And Other Income
InterestAndOtherIncome
1177000
us-gaap Interest And Other Income
InterestAndOtherIncome
809000
CY2016Q4 us-gaap Interest Expense
InterestExpense
343000
CY2015Q4 us-gaap Interest Expense
InterestExpense
355000
us-gaap Interest Expense
InterestExpense
1010000
us-gaap Interest Expense
InterestExpense
1080000
us-gaap Interest Paid Net
InterestPaidNet
1084000
us-gaap Interest Paid Net
InterestPaidNet
823000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3048000
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2172000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6822000
CY2016Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5462000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
376000
CY2016Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
365000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2341000
CY2016Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2215000
CY2016Q4 us-gaap Liabilities
Liabilities
127887000
CY2016Q1 us-gaap Liabilities
Liabilities
133910000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310044000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314777000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13613000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16678000
CY2016Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1000
CY2015Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2016Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
69750000
CY2016Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72000000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 18pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div></div><div style="display: inline; font-weight: bold;">.</div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">CONTINGENCIES</div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Litigation</div></div>&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to a number of proceedings, lawsuits and other claims related to environmental, employment, product and other matters. The Company is required to assess the likelihood of any adverse judgments or outcomes in these matters as well as potential ranges of probable losses. A determination of the amount of reserves required, if any, for these contingencies is made after careful analysis of each individual issue. The required reserves <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div> change in the future due to new developments in each matter or changes in approach, such as a change in settlement strategy in dealing with these matters. The Company believes that the ultimate disposition of such proceedings, lawsuits and claims will not have a material adverse effect on the Company&#x2019;s liquidity, capital resources or business or its consolidated results of operations, cash flows or financial position.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Environmental Contingencies</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company and certain of its subsidiaries have been named by the Environmental Protection Agency (the &quot;EPA&quot;) or a comparable state agency under the Comprehensive Environmental Response, Compensation and Liability Act (the &quot;Superfund Act&quot;) or similar state law as potentially responsible parties in connection with alleged releases of hazardous substances at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> sites. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Under the Superfund Act and similar state laws, all parties who <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div> have contributed any waste to a hazardous waste disposal site or contaminated area identified by the EPA or comparable state agency <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div> be jointly and severally liable for the cost of cleanup. Generally, these sites are locations at which numerous persons disposed of hazardous waste. In the case of the Company's subsidiaries, generally the waste was removed from their manufacturing facilities and disposed at waste sites by various companies which contracted with the subsidiaries to provide waste disposal services. Neither the Company nor any of its subsidiaries have been accused of or charged with any wrongdoing or illegal acts in connection with any such sites. The Company believes it maintains an effective and comprehensive environmental compliance program.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The insurance carriers who provided general liability insurance coverage to the Company and its subsidiaries for the years during which the Company's subsidiaries' waste was disposed at these sites have in the past reimbursed the Company and its subsidiaries for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of their legal defense and remediation costs associated with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> of these sites. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The total costs incurred by the Company and its subsidiaries in connection with these sites, including legal fees incurred by the Company and its subsidiaries and their assessed share of remediation costs and excluding amounts paid or reimbursed by insurance carriers, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> weeks and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div> weeks, respectively, ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> weeks and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div> weeks, respectively, ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> The Company had no recorded liabilities for environmental matters at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February </div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company does not record environmental liabilities and related legal expenses for which the Company believes that it and its subsidiaries have general liability insurance coverage for the years during which the Company's subsidiaries' waste was disposed at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> sites for which certain subsidiaries of the Company have been named as potentially responsible parties. Pursuant to such general liability insurance coverage, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> insurance carriers reimburse the Company and its subsidiaries for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the legal defense and remediation costs associated with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> sites.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Included in selling, general and administrative expenses are charges for actual expenditures and accruals, based on estimates, for certain environmental matters described above. The Company accrues estimated costs associated with known environmental matters, when such costs can be reasonably estimated and when the outcome appears probable. The Company believes that the ultimate disposition of known environmental matters will not have a material adverse effect on the Company&#x2019;s liquidity, capital resources or business or its consolidated results of operations, cash flows or financial position.</div></div></div>
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
132350000
CY2016Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
139668000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-8320000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-50504000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
6129000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21937000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10666000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6786000
us-gaap Net Income Loss
NetIncomeLoss
6806000
us-gaap Net Income Loss
NetIncomeLoss
13455000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
1875000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
4109000
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
29166000
CY2016Q1 us-gaap Noncurrent Assets
NoncurrentAssets
31345000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1917000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4875000
us-gaap Operating Income Loss
OperatingIncomeLoss
7398000
us-gaap Operating Income Loss
OperatingIncomeLoss
15578000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1125000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1247000
CY2016Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000
CY2015Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
33000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
91000
CY2016Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-340000
CY2015Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-144000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-414000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-126000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
586000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1295000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11925000
us-gaap Payments Of Dividends
PaymentsOfDividends
6070000
us-gaap Payments Of Dividends
PaymentsOfDividends
6129000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
44327000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
92890000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
320000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2329000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1963000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
50650000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
69247000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2026000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19333000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21512000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2250000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7500000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
10000000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
10000000
CY2016Q4 us-gaap Restructuring Charges
RestructuringCharges
113000
CY2015Q4 us-gaap Restructuring Charges
RestructuringCharges
158000
us-gaap Restructuring Charges
RestructuringCharges
206000
us-gaap Restructuring Charges
RestructuringCharges
373000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26658000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25922000
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
26462000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
34323000
us-gaap Sales Revenue Net
SalesRevenueNet
87010000
us-gaap Sales Revenue Net
SalesRevenueNet
110099000
CY2016Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4604000
CY2015Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5264000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15051000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16074000
us-gaap Share Based Compensation
ShareBasedCompensation
968000
us-gaap Share Based Compensation
ShareBasedCompensation
1192000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0223
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.289
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
679329
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
150314
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
21.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1250
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.15
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1226392
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1077328
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.51
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y109D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2015Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1250000
CY2012Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1000000
CY2016Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1531412
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
444834
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
182157000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
180867000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15020000
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
15020000
CY2016Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2015Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7000
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20235000
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20253000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20235000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20386000
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20235000
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20253000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20235000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20379000

Files In Submission

Name View Source Status
0001437749-17-000310-index-headers.html Edgar Link pending
0001437749-17-000310-index.html Edgar Link pending
0001437749-17-000310.txt Edgar Link pending
0001437749-17-000310-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pke-20161127.xml Edgar Link completed
pke-20161127.xsd Edgar Link pending
pke-20161127_cal.xml Edgar Link unprocessable
pke-20161127_def.xml Edgar Link unprocessable
pke-20161127_lab.xml Edgar Link unprocessable
pke-20161127_pre.xml Edgar Link unprocessable
pke20161017_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending